MRNA
$24.72
Revenue | $966Mn |
Net Profits | $-1120Mn |
Net Profit Margins | -115.94% |
Moderna, Inc.’s revenue fell -65.66% since last year same period to $966Mn in the Q4 2024. On a quarterly growth basis, Moderna, Inc. has generated -47.92% fall in its revenue since last 3-months.
Moderna, Inc.’s net profit fell -616.13% since last year same period to $-1120Mn in the Q4 2024. On a quarterly growth basis, Moderna, Inc. has generated -8715.38% fall in its net profits since last 3-months.
Moderna, Inc.’s net profit margin fell -1602.97% since last year same period to -115.94% in the Q4 2024. On a quarterly growth basis, Moderna, Inc. has generated -16644.04% fall in its net profit margins since last 3-months.
EPS Estimate Current Quarter | -3.03 |
EPS Estimate Current Year | -3.03 |
Moderna, Inc.’s earning per share (EPS) estimates for the current quarter stand at -3.03 - a -9.79% fall from last quarter’s estimates.
Moderna, Inc.’s earning per share (EPS) estimates for the current year stand at -3.03.
Earning Per Share (EPS) | -2.91 |
Moderna, Inc.’s earning per share (EPS) fell -629.09% since last year same period to -2.91 in the Q4 2024. This indicates that the Moderna, Inc. has generated -629.09% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2024-08-01 | -3.38 | -3.33 | 1.48% |
2025-02-21 | -2.76 | -2.91 | -5.44% |
2024-05-02 | -3.58 | -3.07 | 14.25% |
2024-11-07 | -1.9 | 0.03 | 101.58% |